GILEAD SCIENCES INC (GILD) Fundamental Analysis & Valuation

NASDAQ:GILD • US3755581036

143.93 USD
-1.21 (-0.83%)
At close: Mar 6, 2026
143.256 USD
-0.67 (-0.47%)
After Hours: 3/6/2026, 8:22:39 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This GILD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

GILD gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 520 industry peers in the Biotechnology industry. While GILD has a great profitability rating, there are some minor concerns on its financial health. GILD has a correct valuation and a medium growth rate. GILD also has an excellent dividend rating. These ratings would make GILD suitable for dividend investing!


Dividend Valuation Growth Profitability Health

9

1. GILD Profitability Analysis

1.1 Basic Checks

  • In the past year GILD was profitable.
  • In the past year GILD had a positive cash flow from operations.
  • GILD had positive earnings in each of the past 5 years.
  • Each year in the past 5 years GILD had a positive operating cash flow.
GILD Yearly Net Income VS EBIT VS OCF VS FCFGILD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

1.2 Ratios

  • With an excellent Return On Assets value of 14.42%, GILD belongs to the best of the industry, outperforming 95.19% of the companies in the same industry.
  • With an excellent Return On Equity value of 37.49%, GILD belongs to the best of the industry, outperforming 98.08% of the companies in the same industry.
  • The Return On Invested Capital of GILD (19.49%) is better than 97.50% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for GILD is in line with the industry average of 19.05%.
  • The 3 year average ROIC (17.55%) for GILD is below the current ROIC(19.49%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.42%
ROE 37.49%
ROIC 19.49%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
GILD Yearly ROA, ROE, ROICGILD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • GILD has a Profit Margin of 28.90%. This is amongst the best in the industry. GILD outperforms 95.38% of its industry peers.
  • In the last couple of years the Profit Margin of GILD has grown nicely.
  • The Operating Margin of GILD (39.98%) is better than 98.46% of its industry peers.
  • GILD's Operating Margin has been stable in the last couple of years.
  • The Gross Margin of GILD (78.83%) is better than 84.81% of its industry peers.
  • In the last couple of years the Gross Margin of GILD has remained more or less at the same level.
Industry RankSector Rank
OM 39.98%
PM (TTM) 28.9%
GM 78.83%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
GILD Yearly Profit, Operating, Gross MarginsGILD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. GILD Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so GILD is creating value.
  • The number of shares outstanding for GILD has been reduced compared to 1 year ago.
  • The number of shares outstanding for GILD has been reduced compared to 5 years ago.
  • GILD has a better debt/assets ratio than last year.
GILD Yearly Shares OutstandingGILD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
GILD Yearly Total Debt VS Total AssetsGILD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 4.59 indicates that GILD is not in any danger for bankruptcy at the moment.
  • GILD has a Altman-Z score of 4.59. This is in the better half of the industry: GILD outperforms 71.73% of its industry peers.
  • The Debt to FCF ratio of GILD is 2.64, which is a good value as it means it would take GILD, 2.64 years of fcf income to pay off all of its debts.
  • GILD's Debt to FCF ratio of 2.64 is amongst the best of the industry. GILD outperforms 92.88% of its industry peers.
  • A Debt/Equity ratio of 0.97 indicates that GILD is somewhat dependend on debt financing.
  • GILD's Debt to Equity ratio of 0.97 is on the low side compared to the rest of the industry. GILD is outperformed by 74.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 2.64
Altman-Z 4.59
ROIC/WACC2.39
WACC8.14%
GILD Yearly LT Debt VS Equity VS FCFGILD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 1.55 indicates that GILD should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.55, GILD is not doing good in the industry: 80.38% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.40 indicates that GILD should not have too much problems paying its short term obligations.
  • GILD's Quick ratio of 1.40 is on the low side compared to the rest of the industry. GILD is outperformed by 80.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.4
GILD Yearly Current Assets VS Current LiabilitesGILD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. GILD Growth Analysis

3.1 Past

  • GILD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.79%, which is quite impressive.
  • The Earnings Per Share has been growing slightly by 2.83% on average over the past years.
  • Looking at the last year, GILD shows a small growth in Revenue. The Revenue has grown by 2.40% in the last year.
  • GILD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.58% yearly.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%

3.2 Future

  • Based on estimates for the next years, GILD will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.47% on average per year.
  • GILD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.32% yearly.
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue Next Year3.45%
Revenue Next 2Y4.63%
Revenue Next 3Y4.54%
Revenue Next 5Y4.32%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GILD Yearly Revenue VS EstimatesGILD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
GILD Yearly EPS VS EstimatesGILD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. GILD Valuation Analysis

4.1 Price/Earnings Ratio

  • GILD is valuated rather expensively with a Price/Earnings ratio of 17.66.
  • Based on the Price/Earnings ratio, GILD is valued cheaply inside the industry as 93.85% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of GILD to the average of the S&P500 Index (26.29), we can say GILD is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 16.14, the valuation of GILD can be described as correct.
  • 95.00% of the companies in the same industry are more expensive than GILD, based on the Price/Forward Earnings ratio.
  • GILD is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.66
Fwd PE 16.14
GILD Price Earnings VS Forward Price EarningsGILD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • GILD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GILD is cheaper than 95.00% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GILD indicates a rather cheap valuation: GILD is cheaper than 95.96% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.89
EV/EBITDA 13.37
GILD Per share dataGILD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GILD does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of GILD may justify a higher PE ratio.
PEG (NY)1.87
PEG (5Y)6.25
EPS Next 2Y8.64%
EPS Next 3Y8.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. GILD Dividend Analysis

5.1 Amount

  • GILD has a Yearly Dividend Yield of 2.28%.
  • Compared to an average industry Dividend Yield of 1.19, GILD pays a better dividend. On top of this GILD pays more dividend than 98.46% of the companies listed in the same industry.
  • GILD's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.28%

5.2 History

  • The dividend of GILD has a limited annual growth rate of 3.30%.
  • GILD has been paying a dividend for at least 10 years, so it has a reliable track record.
  • GILD has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)3.3%
Div Incr Years9
Div Non Decr Years9
GILD Yearly Dividends per shareGILD Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • 47.04% of the earnings are spent on dividend by GILD. This is a bit on the high side, but may be sustainable.
  • The dividend of GILD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP47.04%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
GILD Yearly Income VS Free CF VS DividendGILD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B
GILD Dividend Payout.GILD Dividend Payout, showing the Payout Ratio.GILD Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GILD Fundamentals: All Metrics, Ratios and Statistics

GILEAD SCIENCES INC

NASDAQ:GILD (3/6/2026, 8:22:39 PM)

After market: 143.256 -0.67 (-0.47%)

143.93

-1.21 (-0.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10
Earnings (Next)04-22
Inst Owners91.58%
Inst Owner Change0.54%
Ins Owners0.07%
Ins Owner Change0.59%
Market Cap178.57B
Revenue(TTM)29.44B
Net Income(TTM)8.51B
Analysts81.62
Price Target159.01 (10.48%)
Short Float %1.77%
Short Ratio2.91
Dividend
Industry RankSector Rank
Dividend Yield 2.28%
Yearly Dividend3.22
Dividend Growth(5Y)3.3%
DP47.04%
Div Incr Years9
Div Non Decr Years9
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.2%
Min EPS beat(2)0.73%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)3.61%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)7
Avg EPS beat(8)10.97%
EPS beat(12)8
Avg EPS beat(12)7.27%
EPS beat(16)12
Avg EPS beat(16)9.04%
Revenue beat(2)2
Avg Revenue beat(2)1.64%
Min Revenue beat(2)0.98%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)2.29%
Revenue beat(8)6
Avg Revenue beat(8)1.67%
Revenue beat(12)8
Avg Revenue beat(12)0.99%
Revenue beat(16)12
Avg Revenue beat(16)2.6%
PT rev (1m)15.95%
PT rev (3m)19%
EPS NQ rev (1m)-7.95%
EPS NQ rev (3m)-7.15%
EPS NY rev (1m)-0.14%
EPS NY rev (3m)1.15%
Revenue NQ rev (1m)-0.69%
Revenue NQ rev (3m)-1.32%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 17.66
Fwd PE 16.14
P/S 6.06
P/FCF 18.89
P/OCF 17.83
P/B 7.87
P/tB N/A
EV/EBITDA 13.37
EPS(TTM)8.15
EY5.66%
EPS(NY)8.92
Fwd EY6.2%
FCF(TTM)7.62
FCFY5.29%
OCF(TTM)8.07
OCFY5.61%
SpS23.73
BVpS18.3
TBVpS-2.09
PEG (NY)1.87
PEG (5Y)6.25
Graham Number57.93
Profitability
Industry RankSector Rank
ROA 14.42%
ROE 37.49%
ROCE 24.94%
ROIC 19.49%
ROICexc 25.18%
ROICexgc 81.81%
OM 39.98%
PM (TTM) 28.9%
GM 78.83%
FCFM 32.11%
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
ROICexc(3y)21.91%
ROICexc(5y)20.22%
ROICexgc(3y)88.7%
ROICexgc(5y)94.18%
ROCE(3y)22.46%
ROCE(5y)21.44%
ROICexgc growth 3Y-8.45%
ROICexgc growth 5Y-2.47%
ROICexc growth 3Y8.85%
ROICexc growth 5Y10%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
F-Score8
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 2.64
Debt/EBITDA 1.52
Cap/Depr 20.4%
Cap/Sales 1.91%
Interest Coverage 11.36
Cash Conversion 68.94%
Profit Quality 111.11%
Current Ratio 1.55
Quick Ratio 1.4
Altman-Z 4.59
F-Score8
WACC8.14%
ROIC/WACC2.39
Cap/Depr(3y)20.34%
Cap/Depr(5y)24.78%
Cap/Sales(3y)1.96%
Cap/Sales(5y)2.14%
Profit Quality(3y)796.33%
Profit Quality(5y)548.85%
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%
Revenue Next Year3.45%
Revenue Next 2Y4.63%
Revenue Next 3Y4.54%
Revenue Next 5Y4.32%
EBIT growth 1Y8.73%
EBIT growth 3Y1.14%
EBIT growth 5Y3.47%
EBIT Next Year18.57%
EBIT Next 3Y11.36%
EBIT Next 5Y8.77%
FCF growth 1Y-8.25%
FCF growth 3Y4.25%
FCF growth 5Y4.69%
OCF growth 1Y-7.48%
OCF growth 3Y3.36%
OCF growth 5Y4.17%

GILEAD SCIENCES INC / GILD FAQ

What is the ChartMill fundamental rating of GILEAD SCIENCES INC (GILD) stock?

ChartMill assigns a fundamental rating of 7 / 10 to GILD.


What is the valuation status for GILD stock?

ChartMill assigns a valuation rating of 6 / 10 to GILEAD SCIENCES INC (GILD). This can be considered as Fairly Valued.


How profitable is GILEAD SCIENCES INC (GILD) stock?

GILEAD SCIENCES INC (GILD) has a profitability rating of 9 / 10.


What is the valuation of GILEAD SCIENCES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for GILEAD SCIENCES INC (GILD) is 17.66 and the Price/Book (PB) ratio is 7.87.


How sustainable is the dividend of GILEAD SCIENCES INC (GILD) stock?

The dividend rating of GILEAD SCIENCES INC (GILD) is 7 / 10 and the dividend payout ratio is 47.04%.